Patient # | Primary tumor site Site1# | Metastatic/Re-biopsy tumor site Site2# | Ki-67 index (%) | Survival time | WHO class change | |
---|---|---|---|---|---|---|
Site1# | Site2# | |||||
1 | pancreas | peritoneum | 70 | 70 | 12 | – |
2 | pancreas | lymph node | 10 | 30 | 15 | G2 → G3 |
3 | pancreas | peritoneum | 5 | 20 | 6 | G2 → G2 |
4 | pancreas | liver | 5 | 5 | 11 | – |
5 | pancreas | liver | 2 | 2 | 12 | – |
6 | pancreas | pancreas | 1 | 1 | 24 | – |
7 | pancreas | liver | 1 | 1 | 38 | – |
8 | rectum | lymph node | 70 | 70 | 12 | – |
9 | rectum | liver | 50 | 80 | 16 | G3 → G3 |
10 | rectum | liver | 2 | 5 | 13 | G1 → G2 |
11 | rectum | liver | 2 | 1 | 5 | G1 → G1 |
12 | rectum | liver | 2 | 5 | 3 | G1 → G2 |
13 | rectum | lymph node | 70 | 90 | 8 | G3 → G3 |
14 | rectum | lymph node | 2 | 5 | 7 | G1 → G2 |
15 | rectum | liver | 2 | 2 | 14 | – |
16 | rectum | liver | 10 | 10 | – | – |
17 | rectum | rectum | 80 | 60 | 12 | G3 → G3 |
18 | rectum | lymph node | 60 | 80 | – | G3 → G3 |
19 | stomach | lymph node | 2 | 5 | 12 | G1 → G2 |
20 | stomach | lymph node | 60 | 80 | 14 | G3 → G3 |
21 | stomach | liver | 1 | 1 | 24 | – |
22 | stomach | lymph node | 60 | 40 | 22 | G3 → G3 |
23 | stomach | lymph node | 5 | 5 | 27 | – |
24 | stomach | stomach | 50 | 80 | – | G3 → G3 |
25 | stomach | stomach | 70 | 30 | 33 | G3 → G3 |
26 | stomach | stomach | 30 | 40 | 21 | G3 → G3 |
27 | stomach | pancreas | 70 | 70 | 8 | – |
28 | stomach | stomach | 5 | 5 | 60 | – |
29 | ileocecal junction | lymph node | 70 | 70 | 16 | – |
30 | duodenum | liver | 5 | 5 | 12 | – |